Literature DB >> 19837022

Developmental dysplasia of the hip: is acetabular retroversion a crucial factor?

A Nehme1, R Trousdale, Z Tannous, G Maalouf, J Puget, N Telmont.   

Abstract

OBJECTIVE: The objective of this study was to investigate a possible relation between congenital hip dysplasia and acetabular retroversion and to explore the eventual influence of the latter in the surgical decision for periacetabular osteotomy.
MATERIALS AND METHODS: We assessed the classical morphological characteristics of both hips, with an additional newly described retroversion index. The study was conducted in 174 patients with uni- or bilateral congenital hip dysplasia having undergone unilateral (153 patients) or bilateral (21 patients) periacetabular osteotomy when respectively one or both dysplastic hips remained symptomatic.
RESULTS: In the group of operated hips (195 hips in total), 53% of the acetabuli were anteverted, 42% retroverted, and 5% neutral orientations. The group of nonoperated hips (153 hips) included 24% normal hips, 22% hips with normal coverage but retroverted, 35% dysplastic hips with anteverted or neutral orientation, and 19% dysplastic retroverted hips. Comparing the two hips in the subgroup of patients in whom the operated and nonoperated sides were both dysplastic failed to demonstrate statistically significant difference in the mean retroversion index. However, all the other variables measured were significantly different; with the operated side more dysplastic. Comparing the two hips in the other subgroups showed that acetabular retroversion was nearly always bilateral and symmetrical, even in presence of unilateral congenital dysplasia. DISCUSSION: Our data suggest that the presence of acetabular retroversion is probably independent of the congenital hip dysplasia and that this abnormality seems at best a secondary factor in the appearance of dysplastic hip symptoms. LEVEL OF EVIDENCE: Level IV, retrospective diagnostic study. 2009 Published by Elsevier Masson SAS.

Entities:  

Mesh:

Year:  2009        PMID: 19837022     DOI: 10.1016/j.otsr.2009.06.006

Source DB:  PubMed          Journal:  Orthop Traumatol Surg Res        ISSN: 1877-0568            Impact factor:   2.256


  7 in total

1.  New radiographic index for evaluating acetabular version.

Authors:  Hiroshi Koyama; Hironobu Hoshino; Daisuke Suzuki; Shoichi Nishikino; Yukihiro Matsuyama
Journal:  Clin Orthop Relat Res       Date:  2012-12-22       Impact factor: 4.176

Review 2.  Radiographic outcomes following femoroacetabular impingement correction with open surgical management: a systematic review.

Authors:  R Kyle Martin; Ivan Dzaja; Jeffrey Kay; Muzammil Memon; Andrew Duong; Nicole Simunovic; Olufemi R Ayeni
Journal:  Curr Rev Musculoskelet Med       Date:  2016-12

3.  The Ischial Spine in Developmental Hip Dysplasia: Unraveling the Role of Acetabular Retroversion in Periacetabular Osteotomy.

Authors:  Gerard El-Hajj; Hicham Abdel-Nour; Rami Ayoubi; Joseph Maalouly; Fouad Jabbour; Raja Ashou; Alexandre Nehme
Journal:  Adv Orthop       Date:  2020-08-18

4.  Gender and racial differences in focal and global acetabular version.

Authors:  Eric Tannenbaum; Nathan Kopydlowski; Matthew Smith; Asheesh Bedi; Jon K Sekiya
Journal:  J Arthroplasty       Date:  2013-06-18       Impact factor: 4.757

5.  Is labral hypotrophy correlated with increased acetabular depth?

Authors:  Felix Toft; Elmar Anliker; Martin Beck
Journal:  J Hip Preserv Surg       Date:  2015-05-18

6.  Female Sex Is a Risk Factor for Failure of Hip Arthroscopy Performed for Acetabular Retroversion.

Authors:  Kirsten L Poehling-Monaghan; Aaron J Krych; Bruce A Levy; Robert T Trousdale; Rafael J Sierra
Journal:  Orthop J Sports Med       Date:  2017-11-15

7.  Joint kinematics and kinetics during walking and running in 32 patients with hip dysplasia 1 year after periacetabular osteotomy.

Authors:  Julie S Jacobsen; Dennis B Nielsen; Henrik Sørensen; Kjeld Søballe; Inger Mechlenburg
Journal:  Acta Orthop       Date:  2014-09-05       Impact factor: 3.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.